A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Creatine Kinase Fraction, CK-MB FRACTION
Test CodeCPKMB
Alias/See Also
CKMB, CKMB FRACTION
CPT Codes
82553, 82550
Includes
CPK: Creatine Kinase
CKMB: CK-MB Fraction
CKMBC: CPK-MB%Index
CKMB: CK-MB Fraction
CKMBC: CPK-MB%Index
Preferred Specimen
Light GREEN (PST)
Other Acceptable Specimens
Serum (Red) or Gold (SST) or Orange (OJ) or Tiger Top Serum
Instructions
Includes total CK
Specimen Stability
If samples cannot be assayed within 8 hours, refrigerate samples at 2-8ºC.
If the assay cannot be completed within 48 hours, or for the shipment of samples, freeze at -20ºC or colder. Samples can only be thawed once. Samples should not be thawed in a water bath. Mix gently by inversion and centrifuge after thawing prior to sample analysis.
If the assay cannot be completed within 48 hours, or for the shipment of samples, freeze at -20ºC or colder. Samples can only be thawed once. Samples should not be thawed in a water bath. Mix gently by inversion and centrifuge after thawing prior to sample analysis.
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Avoid assaying lipemic, icteric, or hemolyzed samples.
Setup Schedule
24x7
Reference Range
CPK CRMC and CCMC:
Female: 26-140 U/L Male: 38-174
CPK FHSH:
Female: 26-192 U/L Male: 39-308
CKMB: 0-4.9 ng/mL
CKMBC (MB% Index): 0.0-2.4%
Female: 26-140 U/L Male: 38-174
CPK FHSH:
Female: 26-192 U/L Male: 39-308
CKMB: 0-4.9 ng/mL
CKMBC (MB% Index): 0.0-2.4%
Clinical Significance
CK-MB isoenzyme is located primarily in the myocardium, representing 20% of the total CK activity. Amounts greater than 5% can be found in the prostate, spleen or skeletal muscle, where quantities of CK-MB may change as a function of the muscle type. After an acute myocardial infarction (AMI), CK-MB appears in the circulation, reflecting damage to the myocardium. CK-MB rises rapidly to peak levels (within 12 hours) then declines to normal levels (36-72 hours). This pattern of rising and falling CK-MB values, along with evolutionary changes in the ECG and a history of chest pain, is generally considered diagnostic of AMI. Measurements of CK-MB can also aid in the non-invasive assessment of the efficacy of myocardial reperfusion following thrombolytic therapy. Elevated levels of CK-MB are also associated with skeletal muscle trauma, but don't have the rise and fall characteristics of CK-MB level in AMI.
Performing Laboratory
CRMC Laboratory (CPK, CKMB)
CCMC Laboratory (CPK)
FHSH Laboratory (CPK)